Core Viewpoint - The upcoming week will see 35 stocks in the A-share market facing the lifting of lock-up restrictions, with a total of 3.942 billion shares being released, amounting to a market value of approximately 99.964 billion yuan, which is a decrease of 56.93% compared to the previous week [1][2]. Summary by Category Stock Unlocking Details - Among the 35 stocks, the largest unlock market value will be from United Imaging Healthcare at over 29 billion yuan, followed by GeKong Microelectronics at over 16 billion yuan, and Hualan Biological Engineering at approximately 8.5 billion yuan [2][4]. - The unlocking dates for key stocks are as follows: United Imaging Healthcare on August 22 with 23.09 million shares, GeKong Microelectronics on August 18 with 105 million shares, and Hualan Biological Engineering on August 18 with 4.59 million shares [2][4]. Market Performance - As of August 15, the stock price changes since August for United Imaging Healthcare, GeKong Microelectronics, and Hualan Biological Engineering are -4.01%, +2.03%, and -2.11% respectively [3]. Unlocking Proportions - Six stocks will see their unlocking shares exceed 50% of their total share capital, including Hualan Biological Engineering (76.37%), GeKong Microelectronics (67.76%), and others, leading to significant increases in their circulating shares [8][9]. - The total number of stocks with a circulation increase of over 100% after unlocking will be eight, including notable increases for Hualan Biological Engineering and GeKong Microelectronics [8]. Detailed Stock Information - The detailed unlocking information for United Imaging Healthcare shows that its largest shareholders include United Imaging Technology Group and Shanghai Ying Sheng Investment Partnership, with a total unlocking of 16.76 million shares valued at approximately 21.44 billion yuan [6]. - For GeKong Microelectronics, the largest shareholder is Uni-sky Holding Limited, with an unlocking of 105 million shares valued at approximately 16.39 billion yuan [7].
下周A股解禁市值近千亿元环比减少56.93%:联影医疗将解禁市值超290亿元,华兰疫苗流通盘将增加324%